Consistent with this, and in agreement with the proteomic analyses described above [126], elevated OPN levels in CSF are also increased in patients with mild cognitive impairment (MCI) that progress to AD, but not in patients with stable MCI [116] (see Figure 2). Here, SPP1 is linked to Alzheimer disease.